Medical Health Cluster


WHO recommends two new drugs to treat COVID-19

WHO has recommended two new drugs for COVID-19, providing yet more options for treating the disease. The extent to which these medicines will save lives depends on how widely available and affordable they will be. The first drug, baricitinib, is strongly recommended for patients with severe or critical COVID-19. It […]

Read More

Europe is facing 700,000 more Covid deaths — but masks could prevent many of them, WHO says

Europe could suffer another 700,000 Covid-19 deaths by March, the World Health Organization (WHO) has said. It’s the latest in a series of dire warnings for the region, which is in the grip of a devastating fourth wave of cases that has plunged several countries back into lockdown. More than 1.5 million […]

Read More

COVID-19 deaths in European region on course to exceed 2M by March, warns WHO

Over two million people in the European region are expected to have died from COVID-19 by March 2022, according to estimates from the World Health Organization’s Europe office. Tuesday’s grim projection from the WHO includes data indicating that deaths due to the virus doubled last week compared to the end […]

Read More


7 Vaccines Approved for Use by WHO Moderna mRNA-1273 This vaccine is approved. Approved in 76 countries 30 trials in 2 countries Approval Source:  RNA Pfizer/BioNTech BNT162b2 This vaccine is approved. Approved in 103 countries 37 trials in 2 countries Approval Source:  RNA Janssen (Johnson & Johnson) Ad26.COV2.S This vaccine is approved. Approved in 75 […]

Read More

WHO Proposes Fresh Mission to China and Lab Audits: Diplomats

GENEVA (Reuters) – The World Health Organization has proposed a second phase of studies in China into the origins of the coronavirus, including audits of laboratories in Wuhan, but there is no sign yet that Beijing would accept a further international probe, diplomats said. WHO director-general Tedros Adhanom Ghebreyesus presented […]

Read More

WHO recommends life-saving interleukin-6 receptor blockers for COVID-19 and urges producers to join efforts to rapidly increase access

The World Health Organization (WHO) has updated its patient care guidelines to include interleukin-6 receptor blockers, a class of medicines that are lifesaving in patients who are severely or critically ill with COVID-19, especially when administered alongside corticosteroids. These were the findings from a prospective and a living network meta-analysis […]

Read More